PSI: Dedicated to Helping People
Our greatest passion is striving to provide the best possible psychedelic therapy model to facilitate core healing. And to disseminate the knowledge we learn to other therapists throughout the world.
Saj Razvi, LPC. is a psychotherapist and Director of Education at PSI. He is a faculty member at Mind Medicine Australia and he was a clinical researcher in the MAPS Phase 2 trial of MDMA-assisted therapy. Saj is the primary author of the Psychedelic Somatic Interactional Psychotherapy (PSIP) treatment manual. He has taught trauma studies as faculty at the University of Denver as well as being a national topic expert for PESI education seminars focusing on complex trauma. Saj’s primary interest is in the development of psychotherapeutic interventions that maximize the healing capacity of psychedelic medicine, and the grass roots availability of psychedelic therapy. Saj had also participated in a harm reduction effort in 2015 which led him to the decision of forfeiting his psychotherapy license in the state of Colorado, read his story here.
Steven is the Director of Community Outreach for PSI. Steven was also the Founder and Executive Director for OmTerra, a non-profit focused on psychedelic therapy advocacy and education. He was a participant in the Phase 1 FDA Pharmacokinetic Study of Psilocybin at UW-Madison. Steven had a first-hand experience of the benefits and shortcomings of the current model used in psychedelic therapy. Steven brings 30 years of corporate experience in education and marketing to PSI and happily brings to PSI his incredible passion for psychedelic therapy and his commitment to help people who are suffering.
Listen to a podcast with Steven and Martin Ball on the Entheogenic Evolution.